Medical News

Apyrexia Improves the Prognostic Value of Quick SOFA in Olde...
Infection

Temperature at admission was strongly correlated with mortality in these two cohorts of older patients hospitalized...

30 Nov 2022

Use of Point-of-Care USG in the NICU for Diagnostic and Proc...
Pediatrics.

This clinical report describes the current landscape of neonatal POCUS, outlines barriers for implementation, and...

29 Nov 2022

The Effect of The Acute Phase of Infection on Absorption of...
J Antimicrob Chemother

The acute phase of infection in non-critically ill febrile patients does not influence the exposure to, or PTA of,...

28 Nov 2022

Initial Empirical Antibiotics of Non-Carbapenems for ESBL-Pr...
BMC Infect Dis

The empirical use of non-carbapenems might not be a risk factor for mortality and early microbiological outcomes in...

24 Nov 2022

Key Trials

Treatment with Casirivimab and Imdevimab Lowers Hospitalization Rates in High Risk Patients with Mild-to-Moderate COVID-19

The results of this real-world study demonstrated that treatment with casirivimab-imdevimab significantly lowered the rate of hospitalization among...

Casirivimab and Imdevimab Antibody Cocktail Clinically Beneficial in High Risk COVID-19 Patients

Casirivimab and Imdevimab antibody cocktail resulted in lesser requirement of mechanical ventilation and high-flow oxygen with no deaths as compared...

RECOVERY Trial: Efficacy and Safety of Casirivimab and Imdevimab Combination in Hospitalized COVID-19 Patients

RECOVERY Trial evaluated efficacy and safety of casirivimab and imdevimab combination in hospitalized COVID-19 patients. The study showed that in...

REGEN-COV Reduces Risk of Hospitalization and Shortens Time to Resolution of Symptoms in Symptomatic COVID-19 Patients

As per the results of this phase 3, administration of REGEN-COV decreased the risk of Covid-19–related hospitalization or death from any cause....

Slide Library

Cefuroxime (Novacef)

Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....

 
Email this page
Management of Mucormycosis in ENT Practice

Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...

 
Email this page
Antifungal Therapy in Immunocompromised Patients

Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...

 
Email this page
Disseminated Tuberculosis with ARDS

Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...

 
Email this page

Our Publications

Barijak (Barictinib) Monograph

Barictinib can be useful addition for treatment of Moderate to Severe Covid 19 patients in combination with Remdesivir. Barcitinib inhibits the...

Cipmolnu (Molnupiravir) Monograph

This monograph overviews in-vitro/clinical evidence for Molnupiravir efficacy, safety and positioning.

Molnupiravir: Fact Sheet for Healthcare Givers and Recipients

This fact sheet contains the factual details about the drug molnupiravir, its restricted use under emergency situation, dosage, side effects etc....

Molnupiravir - FAQ Booklet

This document addresses frequently asked questions related to oral antiviral drug Molnupiravir in the treatment of Covid-19.